Safety of Argatroban Infusion in Conduction Disturbances

Clinical trial NCT05740371 · COMPLETED

Trial details

NCT number: NCT05740371
Sponsor: Tanabe Pharma GmbH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Stable Coronary Artery Disease (CAD)Unstable Angina (Troponin Negative)

Start date: 2017-04-18
Primary completion: 2021-05-06
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.